Abivax S.A. (ABVX) stock

ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 1/30

$90.20−1.24 (-1.36%)

Close on Nov 12, 2026Market cap $7.08BP/E –Yield –

Abivax price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Abivax has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?